Evidence map›Paper›PMID 30140198›Full record

ArticleMolecular syndromology2018

Biallelic

Yoshiro Maezawa, Hisaya Kato, Minoru Takemoto, Aki Watanabe, Masaya Koshizaka, Takahiro Ishikawa, Forough Sargolzaeiaval, Masafumi Kuzuya, Hiroshi Wakabayashi, Takashi Kusaka and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Molecular syndromology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Atherosclerosis and Cardiovascular Diseases in Progeroid Syndromes.Journal of atherosclerosis and thrombosis · 2022
    Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Yoshiro MaezawaDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Hisaya KatoDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Minoru TakemotoDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Aki WatanabeDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Masaya KoshizakaDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Takahiro IshikawaDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Forough SargolzaeiavalDepartment of Pathology, University of Washington, Seattle, WA, USA.
Masafumi KuzuyaDepartment of Community Healthcare and Geriatrics, Nagoya University Graduate School of Medicine, Nagoya.
Hiroshi WakabayashiOkayama City General Medical Center, Okayama.
Takashi KusakaDepartment of Pediatrics, Kagawa University, Kagawa, Japan.
Koutaro YokoteDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Junko OshimaDepartment of Clinical Cell Biology and Medicine, Graduate School of Medicine, Chiba University, Chiba.
Chiba University · JPKagawa University · JPNagoya University · JPOkayama Medical Center · JPUniversity of Washington · US

Funding

International Registry of Werner SyndromeR01CA210916 · NCI · UNIVERSITY OF WASHINGTON · PI JUNKO OSHIMA · 2016 to 2026
$3.8M
NCI NIH HHS R01 CA210916
6 · The paper itself

Abstract

Werner syndrome (WS) is a rare autosomal recessive disorder characterized by systemic accelerated aging. It is caused by pathogenic variants of the

Indexed as

Mendelian disorderProgeroid syndromeWerner syndromeWRN

Identifiers

PMID30140198
PMCPMC6103371
OpenAlexW2803548114

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.